Abiopharma

ITGR Stockholder Alert: Robbins LLP Reminds Investors of the Integer Holdings Corporation Securities Class Action

Johnson & Johnson - U.S. FDA approves AKEEGA® as the first precision therapy for BRCA2-mutated metastatic castration-sensitive prostate cancer with 54% reduction in disease progression vs standard of care*

U.S. FDA approves AKEEGA® as the first precision therapy for BRCA2-mutated metastatic castration-sensitive prostate cancer with 54% reduction in disease progression vs standard of care*

NervGen Pharma Announces Proposed Amendment to Warrants

Milestone Receives FDA Approval of CARDAMYST™ (etripamil) as First and Only Self-Administered Nasal Spray for Adults with Paroxysmal Supraventricular Tachycardia (PSVT)

Deadline Soon: Baxter International, Inc. (BAX) Investors Who Lost Money Urged to Contact The Law Offices of Frank R. Cruz About Securities Fraud Lawsuit

ResMed Inc. Daily Stock Update

Dominari Holdings Announces Change of Record Date and Payment Date for $10 Million Cash Dividend

U.S. FDA Approves NUZOLVENCE® (zoliflodacin), a First-in-Class, Single-dose, Oral Antibiotic for the Treatment of Uncomplicated Urogenital Gonorrhea in Adults and Adolescents

Bausch + Lomb Announces Refinancing of Outstanding Term B Loans